You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 9,987,261

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,987,261

Title:	Substituted diazaspiroalkanes as androgen receptor modulators
Abstract:	Described herein, inter alia, are compounds useful for the prevention or treatment of hyperproliferative diseases or disorders.
Inventor(s):	Jung; Michael E. (Los Angeles, CA), Sawyers; Charles L. (New York, NY), Ouk; Samedy (Los Angeles, CA), Tran; Chris (New York, NY), Wongvipat; John (New York, NY)
Assignee:	The Regents of the University of California (Oakland, CA)
Application Number:	15/181,030
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,987,261
Patent Claims:	1. A capsule comprising a compound having a formula: ##STR00025## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant. 2. The capsule of claim 1, wherein the capsule is coated with gelatin, wax, shellac, or sugar, or a combination thereof. 3. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00026## 4. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00027## 5. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00028## in a range of from 0.0005 to 500 mg. 6. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00029## in a range of from 0.01 to 50 mg. 7. The capsule of claim 1, wherein the capsule comprises the compound having a formula: ##STR00030## in a range of from 0.05 to 10 mg. 8. A tablet comprising a compound having a formula: ##STR00031## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant. 9. The tablet of claim 8, wherein the tablet is coated with gelatin, wax, shellac, or sugar, or a combination thereof. 10. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00032## 11. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00033## 12. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00034## in a range of from 0.0005 to 500 mg. 13. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00035## in a range of from 0.01 to 50 mg. 14. The tablet of claim 8, wherein the tablet comprises the compound having a formula: ##STR00036## in a range of from 0.05 to 10 mg. 15. A pill comprising a compound having a formula: ##STR00037## or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, diluent, or adjuvant. 16. The pill of claim 15, wherein the pill is coated with gelatin, wax, shellac, or sugar, or a combination thereof. 17. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00038## 18. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00039## 19. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00040## in a range of from 0.0005 to 500 mg. 20. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00041## in a range of from 0.01 to 50 mg. 21. The pill of claim 15, wherein the pill comprises the compound having a formula: ##STR00042## in a range of from 0.05 to 10 mg.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.